- Report
- January 2024
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- January 2024
- 200 Pages
Global
From €3961EUR$4,150USD£3,318GBP
- Report
- August 2023
- 145 Pages
Global
From €3006EUR$3,150USD£2,519GBP
- Report
- July 2022
- 159 Pages
Global
€4177EUR$4,377USD£3,500GBP
- Report
- February 2023
- 50 Pages
China
From €2863EUR$3,000USD£2,399GBP
- Report
- January 2024
- 103 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- July 2024
- 280 Pages
Global
From €2534EUR$2,655USD£2,123GBP
- Report
- July 2024
- 280 Pages
Global
From €2534EUR$2,655USD£2,123GBP
- Report
- June 2023
- 277 Pages
Global
From €3522EUR$3,690USD£2,951GBP
The Artificial Kidney market is a subset of the larger Biomaterials market. It is composed of products and services that are used to replace or supplement the functions of a natural kidney. These products and services include dialysis machines, artificial kidneys, and other related medical devices. Artificial kidneys are typically made from biocompatible materials such as polymers, ceramics, and metals. These materials are designed to mimic the natural kidney's ability to filter and remove waste from the body.
The Artificial Kidney market is driven by the increasing prevalence of kidney diseases, as well as the need for more efficient and cost-effective treatments. Additionally, advances in technology have enabled the development of more sophisticated artificial kidneys, which can provide better patient outcomes.
Some of the major companies in the Artificial Kidney market include Baxter International, Fresenius Medical Care, NxStage Medical, Asahi Kasei, and Medtronic. Show Less Read more